Ringold talks about the decision to move away from being a technology based company at Affymax to applying the technology to pharma because of the relatively small life of a leading technology. Because of lack on internal infrastructure, they decided to sell the company and put it into the hands of a bigger company that had the infrastructure and expertise to use the technology. After a global search, Glaxo bought Affymax, he says.
Related
Lisa Alderson,
Genome Medical
Dare to Stretch Your Boundaries [Entire Talk]
Get out of your comfort zone and learn to be adaptable. Breakthroughs don't come from doing what you've always done.
Lisa Alderson,
Genome Medical
Dare to Stretch Your Boundaries [Entire Talk]
Get out of your comfort zone and learn to be adaptable. Breakthroughs don't come from doing what you've always done.
Gabriel Parisi-Amon,
Nebia Shower
A Burnout Manifesto [Entire Talk]
Allow yourself to pause work so you can reflect and decompress. The source of protection from burnout is grounded in your values.
Gabriel Parisi-Amon,
Nebia Shower
A Burnout Manifesto [Entire Talk]
Allow yourself to pause work so you can reflect and decompress. The source of protection from burnout is grounded in your values.
Tracy Chou,
Project Include
Debugging the Brogrammer Culture [Entire Talk]
Constantly ask yourself, 'Who's not in the room?" Championing diversity in tech will result in a more inclusive culture and better products.
Tracy Chou,
Project Include
Debugging the Brogrammer Culture [Entire Talk]
Constantly ask yourself, 'Who's not in the room?" Championing diversity in tech will result in a more inclusive culture and better products.
